CELLSHOT ONCO-LAB

What this means for you

This application is over — abandoned 04 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88661622

Mark type

Stylized text

Filed

21 Oct 2019

Abandoned

04 Feb 2021

Attorney of record

James R Menker

Goods and services

• Class 009 — Scientific and electric apparatus: DNA chips; interfacial energy measuring and analyzing apparatus in the nature of force measurement products, namely, digital force gauges, digital torque gauges and manual and motorized test stands used therewith sold as a unit with the gauges, tension testers; optical profilers; data processing apparatus in the nature of digitizers being measuring instrumentation and apparatus; digital measuring apparatus in the nature of digital multimeters; laboratory equipment and supplies, namely, incubators for cell culture; bioreactor for cell culturing; cell measuring apparatus in the nature of electronic apparatus for electrophysiological measurement of cells; free fatty acid measuring and analyzing apparatus for laboratory use being research laboratory analyzers for measuring and analyzing blood and other bodily fluids; intracellular material injector for laboratory use in the nature of injection instrument with needles, needle-based and needle-free injection systems; gene analyzing and extracting devices, namely, laboratory apparatus and instruments for extracting DNA; laboratory apparatus and instruments, namely, gene amplifiers in the nature of DNA microarrays; measuring devices, electric, namely, electronic apparatus for electrophysiological measurement of cells; contact angle measuring and analyzing apparatus, namely, angle finders; precision measuring apparatus, namely, laboratory equipment and supplies, namely, calipers; surveying instruments
• Class 010 — Medical apparatus: Apparatus for use in medical analysis, namely, medical diagnostic apparatus for testing DNA and RNA samples; diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, and DNA; diabetes measuring apparatus being blood glucose meter; medical immunoassay apparatus, namely, immunochemical testing apparatus for medical use; immunoassay apparatus for diagnostic in the nature of medical diagnostic apparatus for detecting cancer, medical diagnostic apparatus for testing DNA and RNA samples; cell culture instruments for medical use, namely, cell culture chambers; free fatty acid measuring device being medical instruments; measuring instruments for medical purposes for measuring and displaying cancer cells, DNA, blood cells and extra cellular contents; cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; apparatus for analysing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; blood testing apparatus; infusion apparatus for therapeutic purposes, namely, medical apparatus, namely, infusion devices for administering drugs

Owner

• FEMTOBIOMED Inc., Seongnamsi, Gyeonggido, KR

Prosecution history

• 16 Feb 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 15 Feb 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 03 Aug 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 03 Aug 2020 — FINAL REFUSAL E-MAILED
• 03 Aug 2020 — FINAL REFUSAL WRITTEN
• 27 Jul 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 26 Jul 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 26 Jul 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 28 Jan 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 28 Jan 2020 — NON-FINAL ACTION E-MAILED
• 28 Jan 2020 — NON-FINAL ACTION WRITTEN
• 28 Jan 2020 — ASSIGNED TO EXAMINER
• 26 Nov 2019 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
• 26 Nov 2019 — TEAS VOLUNTARY AMENDMENT RECEIVED
• 24 Oct 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED